SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

SCHEDULE OF OTHER CURRENT ASSETS

Other current assets consisted of the following as of September 30, 2021 and December 31, 2020:

	September 30, 2021		December 31, 2020
	(unaudited)
Lab supply inventory	$	2,271	$	2,052
Prepaid expenses		734		625
Other		130		45
Total other current assets	$	3,135	$	2,722

SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
	(unaudited)				(unaudited)
Basic weighted average number of common shares		4,165		4,038		4,119		4,025
Potential dilutive effect of stock-based awards		-		-		-		-
Diluted weighted average number of common shares		4,165		4,038		4,119		4,025

SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2021		2020		2021		2020
	(unaudited)				(unaudited)
Options		684		878		684		878
Restricted stock and restricted stock units (RSUs)		366		28		366		28
Warrants		1,405		1,405		1,405		1,405
		2,455		2,311		2,455		2,311